# Ophthalmology venture grabs investors’ attention, raises $330 million

> **Newsylist Open Intelligence Dossier** · First detected: 2026-06-24 17:31 UTC · Category: Business · Sources: 5 · Current Velocity: 2.8

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| FirstWord PHARMA | Ollin raises $330M to dethrone Roche's Vabsymo in retina diseases | 2026-06-24 11:04 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFA4cW1CVFZSejZxUHBWM2dmaGlPbWpFU20xeWxNTkJaNHYwSGFmVldjbk9reF9BbWw1ZFB4dmN4VEtMUk5lX1NrUnFBdUl6LVp2Wmg0?oc=5) |
| Endpoints News | Ollin nets $330M to run Phase 3 trials of Vabysmo challenger from China | 2026-06-24 11:04 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxNVldvQXFKOTVQNHRDalZKN3p1M1V0bE11NnpRdzE2eXlSa1kzNF9xd1daOFZIUElnRlpyM09zVzRLUWlmT29rdG42cUtaSmlRdDFDeGhkX09VbmE2YzRnMzBYRmdudFZjVUVVbkx4Mll5UVUzZzFLSEZsSU5KcDlMWW1HUFJqUjdycnVzMGNfUHlXOENKTElfV213?oc=5) |
| Business Wire | Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026 | 2026-06-24 11:04 | [Source Link](https://news.google.com/rss/articles/CBMi3wJBVV95cUxPRWxtYjM0ODNpOXJnT0tOTkVmTUFIcG16QjYyb1pzNGMtaHdMczEwZ2gtY3BkZHlLc25CY0sxSXBUSnNtWVd5WGkxWnJVY2ZDak1tVExfdjJod0Z6Tm9nYi1iZDcwTEhsYXNQaURfRUliRk5PYkNMd2JoRjlaenlaaGw5aWdoSWFkTzM5Y1dfNmRwRXdRRHBpcnFqc3ZMeWVNVVhZQmxnOWtvY0lmWEtaN2VGZXlhRDBkeG11N28tYUdqQVNwdmFPajJSX2hzdzJNSXFHazN3NVlJMlYyVUw2OERsMU9BdmYybnJPX2sxME1qTHRKNWxzY1RNNVpHVnBFTlpaQ0tMRFNDYXMwakJxOHFZTVhfMENPcnlDNkdwYkJOOXoxV0YtU1RGQ3J6NmNwU1NHSC1Va2FjdVlieXFXbGxFb0ZpU3k5cWh5WjdOWGJXTy12Vjd) |
| Fierce Biotech | Ollin hauls in $330M to enlist Vabysmo challenger in phase 3 eye disease gauntlet | 2026-06-24 11:04 | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxOME9QR3NjM3hHYmdjYmpLZlh3NVFXRkF5c2dSYy1OSGpkYnVSckxLQm5HeXd6MUp4Q2NwS3ZXaU9zUWpwYnRrUlo1ZDJjMktnSkM0THBxZnRaUGNSVmNEVHVZSEFLRTlCVDFIYWxQeExoZWszRDE4bEdmWGpnWnc1dXJWRnU5T1ZUcWdoZjBTaVRPcnZrXzZkNnpXQkR6d0I5U2lTZWNDRWl1eUc2ZlE?oc=5) |
| statnews.com | Ophthalmology venture grabs investors’ attention, raises $330 million | 2026-06-24 11:04 | [Source Link](https://news.google.com/rss/articles/CBMiggFBVV95cUxOUmoxeE1vQjl0NVMycVN2amRlTXR2MDhkQTFNVmJxcDZEaUx1NTZETTVibElORWpfSzNTb09QZy1XMl9Tb3c5UDlWV0tlcWZ5NG5CSExHUlc4ZUZiWDVwMk9JYTFyOUxXNU9nbW0wbzY0Rk5wMG1hWGRxUGlWRTdjeW9R?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-06-24/ophthalmology-venture-grabs-investors-attention-raises-330-million*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*